Telemedicine systems provide a way to improve clinical care delivery to patients with chronic disease, decreasing hospitalizations and visits to the emergency room. The ability to accurately access patient condition via a combination of advanced testing and telemonitoring creates the opportunity to intervene when what is called for clinically can make a difference.
A telemedicine market research report from Wintergreen Research explores how telemedicine device and software companies will capitalize on the revenue streams that will come from services delivery. Just as cell phones are paid for in conjunction with the services contracts, so also the telemedicine applications will be paid by insurance. In some cases the insurance companies recognize that their long term costs are lower by delivering clinical intervention to try to impact lifestyle for patients with chronic disease conditions.
Tablets like Apple's iPad are poised to change telemedicine. Telemedicine-dedicated device and software markets at $736 million in 2011 are anticipated to reach $2.5 billion by 2018.
A summary for this report and a free sample of the full document are available.
This article originally appeared on EE Times Europe.